Daniel N. Swisher, Jr
2017 - Sunesis Pharmaceuticals
In 2017, Daniel N. Swisher, Jr earned a total compensation of $565.5K as Former CEO and President at Sunesis Pharmaceuticals, a 63% decrease compared to previous year.
Compensation breakdown
| Option Awards | $33,465 |
|---|---|
| Salary | $528,519 |
| Other | $3,466 |
| Total | $565,450 |
Swisher received $528.5K in salary, accounting for 93% of the total pay in 2017.
Swisher also received $33.5K in option awards and $3.5K in other compensation.
Rankings
In 2017, Daniel N. Swisher, Jr's compensation ranked 11,418th out of 14,666 executives tracked by ExecPay. In other words, Swisher earned more than 22.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,418 out of 14,666 | 22nd |
Division Manufacturing | 4,476 out of 5,772 | 23rd |
Major group Chemicals And Allied Products | 1,630 out of 2,075 | 21st |
Industry group Drugs | 1,346 out of 1,731 | 22nd |
Industry Pharmaceutical Preparations | 1,052 out of 1,333 | 21st |
Source: SEC filing on April 25, 2018.
Swisher's colleagues
We found two more compensation records of executives who worked with Daniel N. Swisher, Jr at Sunesis Pharmaceuticals in 2017.
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019